Clinical Trial Update: Study of OT-101 in Treating Myopia [Phase 3]

View source ↗

Summary

A phase 3 study evaluating OT-101 for progressive myopia is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia Progressive

Drugs mentioned

• OT-101 (OT-101)

Snippet

Sponsor: Ocumension (Hong Kong) Limited | Conditions: Myopia, Progressive | Phase 3 | Status: ACTIVE_NOT_RECRUITING